29-Sep-2021 | Market Research Store

According to the report published by the Market Research StoreLeukapheresis Market By Product Type (Leukapheresis Disposables and Leukapheresis Devices), By Application (Research Applications and Therapeutic Applications), and By End-User (Blood Component Providers and Blood Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Hospital and Transfusion Centers): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2021–2026” states that the global demand for the leukapheresis market in 2020 was approximately USD 94.7Million. The market is likely to grow at a CAGR of 38.6% and is anticipated to reach around USD 580.1 Million by 2026.

Leukapheresis refers to a specifically modified apheresis method designed to eliminate leukocytes and return the residual cells like the red blood cells, granulocytes, and platelets to the donor. The leukopaks (LPs) are leukapheresis samples taken from healthy peripheral blood. Leukapheresis is the same as apheresis, where the RBCs or platelets are extracted from blood, and the residual blood is sent to the body’s blood circulation. The separation of white blood cells from the sample of blood, which is occupied with the immune system of the body, is concluded with a medical method, described as leukapheresis. The body’s high white blood cells could result in chronic blood cancers such as chronic lymphocytic leukemia (CLL), and hence leukapheresis is important to be carrying out.

The rising occurrence of hyperleukocytic leukemia is driving the number of therapeutic leukapheresis procedures conducted in the forthcoming years and, thus, support the market growth of the leukapheresis industry. The growing demand for blood donations and leukopaks in clinical research studies are also likely to propel the market expansion in the coming years. Moreover, the growing aged population and the growing occurrence of cancer are projected to drive the growth of the market. Other important factors contributing to the market development are the rising collaborations, partnerships, and regulatory approvals. 

On the other hand, the high expenses of therapeutic leukapheresis and leukopaks, the adoption of leukapheresis and leukopaks among small blood banks, hospitals, and research centers is extremely low, which might slow down the leukapheresis market growth over the analysis period.

The global leukapheresis market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The region of North American region is anticipated to eyewitness a considerable growth rate in the global market of leukapheresis owing to the growing incidence of blood cancer and the incidence of the huge number of top biotechnology companies in this region. Moreover, Asia-Pacific is projected to rise at the highest growth rate in the global leukapheresis market as a result of the promising markets in the region that is becoming the main growth hotspots in the industry. Other factors contributing to Asia-Pacific market growth are the increasing elderly population, mounting incidence of leukemia, the expansion in healthcare infrastructure, the growing public and private investments for the advancement of CAR-T therapy, and the rising amount of clinical trials in the region of China.

Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., Fresenius SE & Co. KGaA, Miltenyi Biotec, Macopharma SA, Terumo BCT Inc., Guangzhou Daji Medical Science and Technology Co. Ltd., PuriBlood Medical Co. Ltd., Beijing ZKSK Technology Co. Ltd., and MEDICA S.p.A are various market players driving in the global leukapheresis market.

Browse the full Leukapheresis Market By Product Type (Leukapheresis Disposables and Leukapheresis Devices), By Application (Research Applications and Therapeutic Applications), and By End-User (Blood Component Providers and Blood Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Hospital and Transfusion Centers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026.” Report at https://www.marketresearchstore.com/market-insights/leukapheresis-market-828634

This report segments the global leukapheresis market as follows:

Global Leukapheresis Market: By Product Type

  • Leukapheresis Disposables
  • Leukapheresis Devices

Global Leukapheresis Market: By Application

  • Research Applications
  • Therapeutic Applications

Global Leukapheresis Market: By End-User

  • Blood Component Providers and Blood Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospital and Transfusion Centers

Global Leukapheresis Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Market Research Store is a single destination for all types of industries, global, and regional reports. We feature large repository of latest industry reports and market statistics published by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available. Our vast database of reports enables our clients to benefit from expert insights on global industries, products, and market trends.

Contact Us:

Market Research Store
244 Fifth Avenue, Suite N202
New York, 10001, United States
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@MarketResearchStore.com
Website: https://www.marketresearchstore.com